Trastuzumab (Herceptin) Infusion Vial from Canada
Trastuzumab is a humanized monoclonal antibody against HER2 protein, used in HER2-positive breast cancer therapy. Classified under HTS 3002.15.00.11 for its immunological role in targeted cancer treatment, supplied in measured dose vials for retail pharmacy sale.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide FDA import permit and lot-specific stability data; maintain 2-8°C throughout shipping
• Label clearly as 'contains monoclonal antibodies' with biotech process details to match HTS description
• Watch for duty-free claims under GSP; pitfall is incomplete biotech modification documentation